Clinical trial Recruiting at 17 sites Observational

Evaluating a new sizing algorithm for transcatheter aortic valve replacement in patients with bicuspid aortic stenosis

Official title: A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve

Run by World Health Research Inc. · NCT06991517 · Data updated 2026-11-12

This study is testing a new sizing method for heart valve replacement to see if it helps people with a specific heart condition feel better after their procedure.

Quick facts

Study typeObservational
SexAll
Enrollment290 (estimated)
SponsorWorld Health Research Inc.
Industry-sponsored
Locations20 sites (St Leonards, New South Wales and 19 other locations)
StatusRecruiting
StartedMay 13, 2025
Main results expectedDecember 2026
Study endsDecember 2031
Registry record updatedJuly 21, 2026
Trial IDNCT06991517 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with bicuspid aortic valve disease and severe aortic stenosis who are eligible for TAVR with a Sapien 3 valve.

Probably not a fit

Patients who are not suitable for TAVR or are treated with a valve other than the Sapien 3 will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the impact of the ABC Bicuspid Sizing Algorithm on clinical outcomes for patients with bicuspid aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. Approximately 290 patients will be enrolled, with their diagnostic images evaluated to determine the appropriate treatment and valve size. The study will track outcomes at baseline, procedure, hospital discharge, and follow-ups at 30 days and one year post-procedure. The study will also utilize advanced imaging techniques and artificial intelligence in select cases to enhance decision-making.

Why it matters

Potential benefit: If successful, this study could improve the technical and device success rates of TAVR procedures for patients with bicuspid aortic stenosis.

How similar studies have gone: While the use of sizing algorithms in TAVR is a growing area of interest, this specific approach using the ABC Bicuspid Sizing Algorithm is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have bicuspid aortic valve disease
* Have severe aortic stenosis or mixed aortic stenosis and regurgitation requiring treatment
* Have no other condition requiring surgical intervention
* Have had a TAVR CT scan (retrospectively gated contrast enhanced acquisition) that is of diagnostic quality and includes multiphase reconstructions of the aortic root at the minimum available slice thickness (with at least three systolic and one diastolic phases)
* Would be treated with a Sapien 3 valve if found to be anatomically suitable for TAVR
* Have a suitable access route for TAVR with a Sapien 3 valve

Exclusion Criteria:

* Are treated with TAVR using a device other than a Sapien 3 valve
* Are unable to be treated with TAVR due to intercurrent illness, clinical instability, or death on waitlist after being accepted for TAVR
* TAVR considered high risk and not feasible due to risk of coronary occlusion, risk of sino tubular junction (STJ) injury and severe LVOT calcification
* Annular area less than 275 mm² or more than 750 mm²

Where it's running

  • North Shore Private Hospital
    St Leonards, New South Wales, Australia
    Recruiting
  • Royal North Shore Hospital
    St Leonards, New South Wales, Australia
    Recruiting
  • The Prince Charles Hospital
    Chermside, Queensland, Australia
    Recruiting
  • St Andrew's War Memorial Hospital
    Spring Hill, Queensland, Australia
    Recruiting
  • The Alfred
    Melbourne, Victoria, Australia
    Recruiting
  • Fiona Stanley Hospital
    Murdoch, Western Australia, Australia
    Recruiting
Show 14 more locations
  • Foothills Medical Centre
    Calgary, Alberta, Canada
    Recruiting
  • NovaScotia Health Authority- Halifax Infimary
    Halifax, NovaScotia, Canada
    Recruiting
  • Hamilton General Hospital
    Hamilton, Ontario, Canada
    Recruiting
  • University of Ottawa Heart Institute
    Ottawa, Ontario, Canada
    Recruiting
  • St. Michael's Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
    Québec, Quebec, Canada
    Recruiting
  • Fundación Cardioinfantil - LaCardio
    Bogotá, Colombia
    Recruiting
  • Centro Médico Nacional Siglo XXI
    Mexico City, Mexico
    Recruiting
  • Wellington Regional Hospital
    Newtown, Wellington Region, New Zealand
    Recruiting
  • Christchurch Hospital
    Christchurch, New Zealand
    Recruiting
  • National Heart Centre Singapore
    Singapore, Singapore
    Recruiting
  • Southlake Regional Health Centre
    Newmarket, Ontario, Canada
    Not yet recruiting
  • Hospital San Juan de Dios
    San José, Provincia de San José, Costa Rica
    Not yet recruiting
  • Ramathibodi Hospital
    Bangkok, Thailand
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.